Soliva, Salvia S.
HRN: 21-40-15 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2022
CEFTRIAXONE 1G (VIAL)
05/21/2022
05/28/2022
IV
1g
OD
Breast Mass
Waiting Final Action